Peijia Medical Limited
HKSE: 9996.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Yi Zhang
- Employees
- 1,047
- Headquarters
- Suzhou, China
- IPO year
- 2020
- Market cap
- HK$3.9B
- Website
- https://www.peijiamedical.com
Loading 9996…
Loading profile data…Frequently asked questions about 9996
What does Peijia Medical Limited (9996.HK) do?
Peijia Medical Limited engages in the research and development of transcatheter valve therapeutic and neuro interventional procedural medical devices. Its transcatheter valve therapeutic products include TaurusOne, a transcatheter aortic valve replacement (TAVR) system; TaurusElite, a retrievable TAVR system; TaurusNXT, a non-glutaraldehyde cros...
Where does 9996.HK trade?
Peijia Medical Limited (9996.HK) trades on the Hong Kong Stock Exchange.
What sector is 9996.HK in?
Peijia Medical Limited (9996.HK) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Peijia Medical Limited?
Yi Zhang is the chief executive officer of Peijia Medical Limited (9996.HK).
Where is Peijia Medical Limited headquartered?
Peijia Medical Limited is headquartered in China.
Does 9996.HK pay a dividend?
Peijia Medical Limited (9996.HK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 9996.HK go public?
Peijia Medical Limited (9996.HK) completed its initial public offering in 2020.